Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Burcon NutraScience Corp
TSX:BU

Watchlist Manager
Burcon NutraScience Corp Logo
Burcon NutraScience Corp
TSX:BU
Watchlist
Price: 2.13 CAD 14.52% Market Closed
Market Cap: CA$27m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+0%
5Y
-31%
10Y
+251%
Liabilities
+
3Y
+742%
5Y
+1 619%
10Y
+4 595%
Equity
+
3Y
-99%
5Y
-100%
10Y
-98%

Balance Sheet Decomposition
Burcon NutraScience Corp

Balance Sheet
Burcon NutraScience Corp

Rotate your device to view
Balance Sheet
Currency: CAD
Mar-2002 Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
1
1
4
1
3
6
4
2
12
10
4
5
1
2
2
5
3
0
15
14
7
1
4
7
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
7
Cash Equivalents
1
1
4
1
3
6
4
2
12
10
4
5
1
2
2
5
3
0
15
14
7
1
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
2
2
2
2
0
1
0
0
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Assets
1
1
4
1
3
6
4
2
14
12
7
7
2
4
3
5
4
1
16
15
8
2
5
8
PP&E Net
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
1
1
1
1
16
PP&E Gross
2
2
1
1
1
1
1
1
0
1
1
1
1
1
1
0
0
0
0
1
1
1
1
16
Accumulated Depreciation
0
1
1
1
2
2
2
2
0
2
3
3
3
3
3
3
3
4
4
4
4
4
5
5
Goodwill
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
16
13
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
2
2
2
1
0
0
0
0
2
4
6
6
5
6
Other Assets
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Total Assets
4
N/A
4
-4%
6
+57%
4
-42%
5
+33%
8
+74%
6
-24%
4
-33%
16
+275%
14
-12%
11
-26%
11
0%
5
-51%
7
+31%
5
-28%
7
+40%
5
-20%
2
-55%
31
+1 171%
38
+21%
29
-22%
10
-66%
13
+30%
31
+137%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
0
0
1
1
0
1
1
1
1
1
1
1
1
1
1
1
1
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
3
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
0
0
0
0
0
0
0
0
0
1
1
0
1
1
1
1
1
4
2
1
1
1
1
4
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
0
7
0
0
5
6
19
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
0
N/A
0
-14%
0
+17%
0
-36%
0
+11%
0
+50%
0
-27%
0
+59%
0
+14%
1
+233%
1
-14%
1
-32%
1
+4%
1
+14%
1
-19%
3
+262%
3
+15%
4
+44%
8
+87%
1
-83%
1
-24%
6
+424%
8
+35%
24
+206%
Equity
Common Stock
9
11
15
15
19
25
26
28
44
47
48
54
54
61
65
70
73
73
98
114
115
115
122
132
Retained Earnings
5
8
10
14
18
21
24
28
32
38
43
49
56
61
67
73
79
84
87
92
102
127
134
144
Additional Paid In Capital
0
1
1
3
4
4
4
4
4
4
4
5
6
6
6
7
8
9
9
14
16
17
17
19
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
Total Equity
4
N/A
4
-4%
6
+59%
3
-43%
5
+34%
8
+75%
6
-23%
4
-36%
16
+298%
13
-18%
9
-27%
10
+4%
4
-56%
6
+34%
4
-29%
4
N/A
2
-43%
2
N/A
23
N/A
36
+58%
28
-22%
4
-85%
5
+24%
7
+35%
Total Liabilities & Equity
4
N/A
4
-4%
6
+57%
4
-42%
5
+33%
8
+74%
6
-24%
4
-33%
16
+275%
14
-12%
11
-26%
11
0%
5
-51%
7
+31%
5
-28%
7
+40%
5
-20%
2
-55%
31
+1 171%
38
+21%
29
-22%
10
-66%
13
+30%
31
+137%
Shares Outstanding
Common Shares Outstanding
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
6
7
7
7
9
13

See Also

Summary
BU intrinsic value, competitors valuation, and company profile.
DCF Valuation
BU stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BU stock valuation using valuation multiples.
Wall Street Estimates
BU price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BU stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.